MEDICENNA THERAPEUTICS CORP's ticker is MDNA and the CUSIP is 58490H107. A total of 26 filers reported holding MEDICENNA THERAPEUTICS CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,424 | -44.7% | 15,000 | -9.6% | 0.00% | -50.0% |
| Q2 2023 | $7,996 | -34.5% | 16,600 | -14.4% | 0.00% | 0.0% |
| Q1 2023 | $12,214 | +37.5% | 19,400 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $8,885 | -44.5% | 19,400 | 0.0% | 0.00% | -75.0% |
| Q3 2022 | $16,000 | -23.8% | 19,400 | +8.4% | 0.00% | 0.0% |
| Q2 2022 | $21,000 | -8.7% | 17,900 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $23,000 | -20.7% | 17,900 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $29,000 | -54.0% | 17,900 | -21.8% | 0.01% | -54.5% |
| Q3 2021 | $63,000 | -8.7% | 22,900 | 0.0% | 0.01% | -15.4% |
| Q2 2021 | $69,000 | -17.9% | 22,900 | +11.4% | 0.01% | -31.6% |
| Q1 2021 | $84,000 | -12.5% | 20,550 | 0.0% | 0.02% | -20.8% |
| Q4 2020 | $96,000 | +26.3% | 20,550 | +12.0% | 0.02% | -4.0% |
| Q3 2020 | $76,000 | – | 18,350 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 350,000 | $1,054,000 | 0.54% |
| AIGH Capital Management LLC | 915,000 | $2,768,000 | 0.50% |
| AWM Investment Company, Inc. | 1,000,000 | $3,017,000 | 0.30% |
| Board of Trustees of The Leland Stanford Junior University | 962,932 | $2,898,000 | 0.27% |
| Worth Venture Partners, LLC | 215,030 | $647,000 | 0.24% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 110,515 | $333,000 | 0.15% |
| INTACT INVESTMENT MANAGEMENT INC. | 385,600 | $1,427,000 | 0.04% |
| Verition Fund Management LLC | 539,051 | $1,623,000 | 0.02% |
| Patriot Financial Group Insurance Agency, LLC | 22,900 | $69,000 | 0.01% |
| Maven Securities LTD | 79,118 | $234,000 | 0.01% |